Overview

An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients

Status:
WITHDRAWN

Trial end date:
2025-12-31

Target enrollment:

Participant gender:

Summary

An exploratory clinical study to evaluate the safety and efficacy of NK cells (combined with standard therapy) in the treatment of solid tumor patients

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

Beijing Kejing Biotechnology Co., Ltd.